Bore Family Office
Valuation Report — Fabrinet (FN) • March 4, 2026
Unlevered DCF (FCFF @ WACC) • Discount Rate: 9.00% • Current Price: $563.87
Prepared by Lurch • Bore Family Office • Data: Finnhub, StockAnalysis.com, S&P Global Market Intelligence
🏢 Business Overview
Fabrinet was founded in 2000 in Bangkok, Thailand, and is headquartered in the Cayman Islands
with primary manufacturing operations in Thailand (Chonburi) and California. The company is a
pure-play contract manufacturer for complex optical, electro-optical, and electro-mechanical
products — essentially the "picks and shovels" for the optical networking and AI infrastructure buildout.
Business Model: Fabrinet is an outsourced manufacturing partner for leading technology companies.
It does not design products — it manufactures them to customer specifications with extremely high
precision. Key customers include Coherent, Lumentum, NVIDIA, and other optical/photonics companies.
The business model is asset-light in design but capital-intensive in execution (high-precision clean rooms).
Revenue Mix (FY2025):
- Optical Communications (~75% of revenue): Transceivers, amplifiers, ROADMs for telecom and
datacom networks. This segment is the primary beneficiary of AI infrastructure buildout — hyperscalers
(Microsoft, Google, AWS, Meta) are deploying massive optical interconnect capacity for AI clusters.
- Non-Optical / Laser (~25% of revenue): Industrial lasers, medical devices, sensors.
More stable, lower-growth segment providing diversification.
AI Optical Tailwind: The surge in AI GPU clusters requires massive optical interconnect
bandwidth. A single AI data center pod can require 10-100x more optical transceivers than a traditional
data center. Fabrinet's precision manufacturing capabilities position it as a key supplier in this
supply chain. FY2026E revenue of $4.68B (+37% YoY) reflects this demand surge.
Key Risk: Fabrinet is a contract manufacturer — it has no proprietary IP and can be displaced
if customers vertically integrate or switch suppliers. Concentration risk: top customers represent a
significant portion of revenue. Capex is front-loaded for capacity that must generate returns over time.
📊 Financial Snapshot
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|
| Revenue ($M) | $2,262 | $2,645 | $2,883 | $3,419 |
| EBITDA ($M) | $243 | $296 | $327 | $378 |
| Operating Income ($M) | $205 | $252 | $278 | $324 |
| Net Income ($M) | $200 | $248 | $296 | $333 |
| EPS (diluted) | $5.36 | $6.73 | $8.10 | $9.17 |
| Free Cash Flow ($M) | $35 | $152 | $366 | $207 |
| Annual DPS | $0.000 | $0.000 | $0.000 | $0.000 |
| Total Debt ($M) | $61 | $13 | $5 | $5 |
| Rev YoY Growth | — | +16.9% | +9.0% | +18.6% |
⚙️ WACC Build (DCF)
| Input | Value | Notes |
|---|
| Risk-Free Rate (Rf) | 4.30% | 10-yr US Treasury yield |
| Beta (β) | 1.450 | Market beta (Finnhub) |
| Equity Risk Premium (ERP) | 5.5% | Damodaran US ERP |
| Cost of Equity (Ke) | 12.28% | Ke = Rf + β × ERP |
| Pre-Tax Cost of Debt | 5.00% | Interest exp / gross debt |
| After-Tax Cost of Debt (Kd) | 4.70% | × (1 − 6%) |
| Weight Equity (We) | 99.7% | Mkt cap $0.0B |
| Weight Debt (Wd) | 0.3% | Gross debt $0.0B |
| WACC | 9.00% | DCF discount rate |
📈 DCF Scenarios


📋 Full 10-Year Projection Tables
Bear Scenario
| Period | Stage | FCFF | PV of FCFF | Cumulative EV |
|---|
| Year 1 | Stage 1 | $0.40B | $0.37B | $0.37B |
| Year 2 | Stage 1 | $0.44B | $0.36B | $0.72B |
| Year 3 | Stage 1 | $0.47B | $0.35B | $1.07B |
| Year 4 | Stage 1 | $0.51B | $0.34B | $1.41B |
| Year 5 | Stage 1 | $0.55B | $0.33B | $1.75B |
| Year 6 | Stage 2 | $0.58B | $0.32B | $2.07B |
| Year 7 | Stage 2 | $0.62B | $0.31B | $2.37B |
| Year 8 | Stage 2 | $0.65B | $0.29B | $2.67B |
| Year 9 | Stage 2 | $0.69B | $0.28B | $2.95B |
| Year 10 | Stage 2 | $0.74B | $0.27B | $3.22B |
| Terminal | — | TV=$9.4B | PV(TV)=$3.5B (52% of EV) | EV=$6.7B |
Base Scenario
| Period | Stage | FCFF | PV of FCFF | Cumulative EV |
|---|
| Year 1 | Stage 1 | $0.45B | $0.41B | $0.41B |
| Year 2 | Stage 1 | $0.54B | $0.45B | $0.87B |
| Year 3 | Stage 1 | $0.65B | $0.50B | $1.36B |
| Year 4 | Stage 1 | $0.78B | $0.55B | $1.91B |
| Year 5 | Stage 1 | $0.93B | $0.60B | $2.52B |
| Year 6 | Stage 2 | $1.02B | $0.61B | $3.13B |
| Year 7 | Stage 2 | $1.13B | $0.62B | $3.74B |
| Year 8 | Stage 2 | $1.24B | $0.62B | $4.37B |
| Year 9 | Stage 2 | $1.36B | $0.63B | $4.99B |
| Year 10 | Stage 2 | $1.50B | $0.63B | $5.63B |
| Terminal | — | TV=$25.7B | PV(TV)=$10.9B (66% of EV) | EV=$16.5B |
Bull Scenario
| Period | Stage | FCFF | PV of FCFF | Cumulative EV |
|---|
| Year 1 | Stage 1 | $0.49B | $0.45B | $0.45B |
| Year 2 | Stage 1 | $0.63B | $0.55B | $1.00B |
| Year 3 | Stage 1 | $0.82B | $0.66B | $1.66B |
| Year 4 | Stage 1 | $1.07B | $0.80B | $2.46B |
| Year 5 | Stage 1 | $1.39B | $0.97B | $3.43B |
| Year 6 | Stage 2 | $1.60B | $1.03B | $4.46B |
| Year 7 | Stage 2 | $1.84B | $1.11B | $5.57B |
| Year 8 | Stage 2 | $2.11B | $1.18B | $6.75B |
| Year 9 | Stage 2 | $2.43B | $1.27B | $8.02B |
| Year 10 | Stage 2 | $2.79B | $1.36B | $9.38B |
| Terminal | — | TV=$72.3B | PV(TV)=$35.1B (79% of EV) | EV=$44.4B |
🔲 Sensitivity Table
| WACC \ gT | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|
| 7.0% | $588 | $629 | $679 | $741 | $822 |
| 7.5% | $534 | $567 | $606 | $654 | $714 |
| 8.0% | $489 | $516 | $547 | $585 | $631 |
| 8.5% | $451 | $473 | $498 | $528 | $564 |
| 9.0% | $418 | $436 | $457 | $481 | $510 |
| 9.5% | $389 | $404 | $422 | $442 | $465 |
| 10.0% | $364 | $377 | $391 | $408 | $427 |
| 10.5% | $341 | $352 | $365 | $379 | $395 |
| 11.0% | $321 | $331 | $341 | $353 | $367 |
Green = >10% above current price. Red = >10% below. Gold = within ±10%.
🏦 Comparable Valuation
| Company | P/E (Fwd) | EV/EBITDA | P/FCF | FCF Yield | Rev Growth |
|---|
| FN (current) | 41.1x | 48.2x | 197x | 0.5% | +37% |
| II-VI / Coherent | 28.5x | 18.3x | 35x | 2.9% | +12% |
| Lumentum (LITE) | 22.0x | 14.8x | 28x | 3.6% | +8% |
| Flex (FLEX) | 14.2x | 10.1x | 18x | 5.6% | +5% |
| Jabil (JBL) | 13.8x | 9.8x | 16x | 6.3% | +4% |
| Peer Average | 19.6x | 13.3x | 24x | 4.6% | +7% |
🔮 Analyst Forecast Section
(a) EPS Consensus
| Year | Low / Actual | Avg | High | # Analysts | Type |
|---|
| 2022 | $5.36 | — | — | — | Actual |
| 2023 | $6.73 | — | — | — | Actual |
| 2024 | $8.10 | — | — | — | Actual |
| 2025 | $9.17 | — | — | — | Actual |
| 2026 | $12.74 | $13.71 | $14.32 | 13 | Estimate |
| 2027 | $14.70 | $16.27 | $17.76 | 12 | Estimate |
(b) Revenue Consensus
| Year | Low / Actual | Avg | High | # Analysts | Type |
|---|
| 2022 | $2.3B | — | — | — | Actual |
| 2023 | $2.6B | — | — | — | Actual |
| 2024 | $2.9B | — | — | — | Actual |
| 2025 | $3.4B | — | — | — | Actual |
| 2026 | $4.4B | $4.7B | $4.8B | 13 | Estimate |
| 2027 | $5.1B | $5.5B | $5.9B | 12 | Estimate |
(c) Individual Analyst Price Targets
Consensus: Avg $489.14 | Range $234–$570
| Analyst | Firm | Rating | PT | Upside |
|---|
| Christopher Rolland | Susquehanna | Buy | $570 | +1.1% |
| Mike Genovese | Rosenblatt | Strong Buy | $550 | -2.5% |
| Tim Long | Barclays | Buy | $548 | -2.8% |
| Ryan Koontz | Needham | Strong Buy | $540 | -4.2% |
| Dave Kang | B. Riley | Hold | $452 | -19.8% |
(d) Earnings Surprise History
| Quarter | EPS Act vs Est | EPS Beat/Miss | Rev Act vs Est | Rev Beat/Miss | Guidance |
|---|
| Q1 FY2025 | $2.17 vs $2.10 | +$0.07 ✅ | $0.8B vs $0.8B | +$0.0B ✅ | Raised |
| Q2 FY2025 | $2.25 vs $2.18 | +$0.07 ✅ | $0.8B vs $0.8B | +$0.0B ✅ | Raised |
| Q3 FY2025 | $2.36 vs $2.28 | +$0.08 ✅ | $0.9B vs $0.9B | +$0.0B ✅ | Raised |
| Q4 FY2025 | $2.39 vs $2.31 | +$0.08 ✅ | $0.9B vs $0.9B | +$0.0B ✅ | Strong FY2026 |
(e) Confidence Band Commentary
Only 7 analysts cover FN — thin coverage creates a wide PT range ($234–$570). The $234 low PT (B. Riley Hold) reflects concern that AI optical capex is a one-time demand pull rather than a secular trend, and that FCF is structurally impaired by ongoing capacity investments. The $570 high (Susquehanna Buy) reflects conviction that AI infrastructure buildout is a multi-year tailwind. Current price $563.87 is already at the top of the PT range — the stock is pricing in the bull case. Four consecutive EPS beats with raised guidance signal operational momentum, but the valuation leaves little room for error.


💡 Investment Thesis
Bull Case: AI infrastructure buildout is a multi-year secular demand wave. Optical transceiver
demand for AI clusters grows 5-10x over the next 3-5 years. Fabrinet's precision manufacturing is
a bottleneck in the supply chain — customers are locked in for years. As the current capex surge
(~$175M TTM vs ~$90M normalized) completes, FCF recovers dramatically. EPS grows from $9.17 (FY2025)
toward $16-17 (FY2027E). Stock can sustain a premium multiple on a growth-adjusted basis.
Bear Case: The AI capex boom is cyclical, not secular. Hyperscaler spending plateaus or
pulls back in 2027, leaving Fabrinet with excess capacity and stranded capital. FCF margins stay
compressed as management continues investing ahead of demand. With no dividend and minimal buybacks
(relative to capex), shareholders have limited return of capital. At 41x forward earnings and 17%
above analyst consensus PT, there is no margin of safety.
Current Assessment: The stock at $563.87 is priced for perfection — already above the
analyst consensus PT of $489 and at the top of the PT range ($570 high). The DCF base case of $481
(anchored to analyst consensus) confirms the stock is trading at a ~17% premium to intrinsic value.
This is a Hold — excellent business in a strong secular trend, but not the right entry point.
Watch for a pullback to the $480-510 range to initiate or add.
⚖️ DCF Verdict: Hold — Fabrinet (FN)
Current price: $563.87 | Analyst Avg PT: $489.14
| Tier | Price | Action |
|---|
| Tier 1 — Starter | ≤$510 | Begin position |
| Tier 2 — Add | ≤$480 | Add on weakness |
| Tier 3 — Full | ≤$440 | Full allocation |
| Sell Alert | ≥$570 | Above fair value — consider trimming |
Bore Family Office • Analysis generated by Lurch • Not investment advice.